Quick Answer
Pelthos Therapeutics Inc. reported Shares Outstanding of 3.23 million shares for fiscal year 2025.
Pelthos Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.23M | +429.9% |
| 2024 | 610,389 | -84.4% |
| 2023 | 3.91M | +251.6% |
| 2022 | 1.11M | -6.4% |
| 2022 | 1.19M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.09M | -46.9% | +359.0% |
| June 30, 2025 | 673,320 | -88.4% | -89.1% |
| March 31, 2025 | 6.18M | +7.2% | +913.1% |
| December 31, 2024 | 610,389 | -84.4% | -89.5% |
| September 30, 2024 | 5.82M | — | -0.1% |
| June 30, 2024 | 5.82M | — | +1.0% |
| March 31, 2024 | 5.77M | — | +47.6% |
| December 31, 2023 | 3.91M | — | +3190.0% |
- Pelthos Therapeutics Inc. showed an increase of +429.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Pelthos Therapeutics Inc.’s shares outstanding has grown by 172.4% (from 1.19 million shares to 3.23 million shares).
- The most recent figure is from Pelthos Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: